This intestinal protein helps reduce obesity

Image
ANI Washington
Last Updated : Dec 25 2014 | 12:25 PM IST

A new study has revealed that the intestine immune system (a protein called MyD88) helps in controlling body weight and to reduce the diabetes type 2, linked to the obesity.

A group of UCL researchers identified an unsuspected mechanism impacting the development of obesity and diabetes type 2 after following a diet with a high dose of fat nutrition.

The team of Professor Patrice D. Cani, in direct collaboration with two French teams, a Swedish expert as well as other UCL-researchers (LDRI and Ludwig Institute), made an important discovery related to the essential role of the intestinal immune system regarding the control of the energy metabolism.

Researchers were able to demonstrate for the very first time that as a result of fat nutrition, the inactivation of a part of the intestine immune system, a protein called MyD88 allows people to lose weight and to reduce the diabetes type 2, linked to the obesity.

More specifically, the team shows that when modifying the response of the immune system by disabling this protein MyD88 only in those cells covering the intestine, this allows to slow down de development of diabetes induced by a diet of fat nutrition, to limit the development of adipose tissue, to reduce the harmful inflammation present because of the obesity and to strengthen the barrier function assured by our intestine and limiting as such the inappropriate transit of bacterial elements of our intestines in our body.

Even more important, the researchers managed to demonstrate that because of this modification within the immunity system, it was experimentally demonstrated possible to lose weight and thus to have a therapeutic effect, even when the animals used for the experiments are already obese and diabetic.

All the research work put together leads thus to the recommendation that during consumption of fat nutrition, the intestine immunity system plays an important role in the fat storage regulation in the body and is literally capable to modify the composition of intestinal bacteria (including some which are still unidentified).

The study is published in the scientific journal Nature Communications.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 25 2014 | 12:09 PM IST

Next Story